METHYS Dx
Liquid biopsy cancer tests
- B2B
About METHYS Dx
Develops innovative liquid biopsy tests for non-invasive cancer patient monitoring using proprietary molecular signatures and ultrasensitive detection technology to improve therapeutic decisions
Key facts
- Industry
- Biotechnology
- Company size
- 11–50 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2021
- Revenue
- $6.1M – $48.1MTamtam estimate
- Website
- methysdx.com
- linkedin.com/company/methys-dx
METHYS Dx at a glance
METHYS Dx is a B2B company in the Biotechnology industry, headquartered in Paris, Île-de-France, France.
METHYS Dx was founded in 2021.
METHYS Dx has 11–50 employees.
METHYS Dx's revenue is $6.1M – $48.1M (Tamtam estimate).
Selling to companies like METHYS Dx?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies